Dimensional Fund Advisors’s Castle Biosciences CSTL Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $28.1M | Buy |
1,378,005
+177,783
| +15% | +$3.63M | 0.01% | 1817 |
|
2025
Q1 | $24M | Buy |
1,200,222
+200,756
| +20% | +$4.02M | 0.01% | 1861 |
|
2024
Q4 | $26.6M | Buy |
999,466
+134,645
| +16% | +$3.59M | 0.01% | 1870 |
|
2024
Q3 | $24.7M | Buy |
864,821
+54,887
| +7% | +$1.57M | 0.01% | 1904 |
|
2024
Q2 | $17.6M | Buy |
809,934
+60,675
| +8% | +$1.32M | ﹤0.01% | 2019 |
|
2024
Q1 | $16.6M | Buy |
749,259
+85,377
| +13% | +$1.89M | ﹤0.01% | 2081 |
|
2023
Q4 | $14.3M | Buy |
663,882
+108,481
| +20% | +$2.34M | ﹤0.01% | 2149 |
|
2023
Q3 | $9.38M | Buy |
555,401
+65,818
| +13% | +$1.11M | ﹤0.01% | 2290 |
|
2023
Q2 | $6.72M | Buy |
489,583
+5,931
| +1% | +$81.4K | ﹤0.01% | 2423 |
|
2023
Q1 | $11M | Buy |
483,652
+159,966
| +49% | +$3.63M | ﹤0.01% | 2190 |
|
2022
Q4 | $7.62K | Buy |
323,686
+85,198
| +36% | +$2.01K | ﹤0.01% | 2319 |
|
2022
Q3 | $6.22M | Buy |
238,488
+46,410
| +24% | +$1.21M | ﹤0.01% | 2351 |
|
2022
Q2 | $4.22M | Buy |
192,078
+69,700
| +57% | +$1.53M | ﹤0.01% | 2501 |
|
2022
Q1 | $5.49M | Buy |
122,378
+8,278
| +7% | +$371K | ﹤0.01% | 2508 |
|
2021
Q4 | $4.89M | Buy |
114,100
+59,783
| +110% | +$2.56M | ﹤0.01% | 2571 |
|
2021
Q3 | $3.61M | Buy |
+54,317
| New | +$3.61M | ﹤0.01% | 2674 |
|
2021
Q2 | – | Sell |
-142,988
| Closed | -$9.76M | – | 3465 |
|
2021
Q1 | $9.76M | Buy |
142,988
+122,306
| +591% | +$8.34M | ﹤0.01% | 2338 |
|
2020
Q4 | $1.39M | Buy |
+20,682
| New | +$1.39M | ﹤0.01% | 2904 |
|